Introduction: Among the chronic and feared complications of this disease, rheumatoid vasculitis stands out as one of the most severe, albeit rare. The most frequently affected sites by rheumatoid vasculitis are the skin and the peripheral nervous system. We report a case of rheumatoid vasculitis complicating a 30-year history of untreated rheumatoid arthritis. Case Report: The patient is a 75-year-old male with a 30-year history of deforming and erosive seropositive rheumatoid arthritis. He presented with polyarthritis and digital necrosis. Physical examination revealed peripheral joint syndrome with characteristic deformities of rheumatoid arthritis. Additionally, there was well-demarcated dry gangrene affecting the first and second digits of the right hand. Laboratory findings indicated an inflammatory syndrome. Tests for antinuclear antibodies (ANA) and anti-neutrophil cytoplasmic antibodies (ANCA) to investigate other causes of vasculitis were negative. The patient received a corticosteroid bolus. After two weeks, there was a marked reduction in pain and an improvement in the general condition. The dry gangrene remained stable. Conclusion: Rheumatoid vasculitis remains a serious and chronic complication of rheumatoid arthritis, associated with significant mortality. This case highlights the crucial importance of early diagnosis and effective management of rheumatoid arthritis.
References
[1]
Smolen, J.S., Aletaha, D. and McInnes, I.B. (2016) Rheumatoid Arthritis. TheLancet, 388, 2023-2038. https://doi.org/10.1016/s0140-6736(16)30173-8
[2]
Makol, A., Crowson, C.S., Wetter, D.A., Sokumbi, O., Matteson, E.L. and Warrington, K.J. (2014) Vasculitis Associated with Rheumatoid Arthritis: A Case-Control Study. Rheumatology, 53, 890-899. https://doi.org/10.1093/rheumatology/ket475
[3]
Genta, M.S., Genta, R.M. and Gabay, C. (2006) Systemic Rheumatoid Vasculitis: A Review. SeminarsinArthritisandRheumatism, 36, 88-98. https://doi.org/10.1016/j.semarthrit.2006.04.006
[4]
Turesson, C. and Jacobsson, L. (2004) Epidemiology of Extra-Articular Manifestations in Rheumatoid Arthritis. ScandinavianJournalofRheumatology, 33, 65-73. https://doi.org/10.1080/03009740310004621
[5]
Laskaria, K., Ahmadi-Simab, K., Lamken, M., Csernok, E., Gross, W.L. and Hellmich, B. (2010) Are Anti-Cyclic Citrullinated Peptide Autoantibodies Seromarkers for Rheumatoid Vasculitis in a Cohort of Patients with Systemic Vasculitis? AnnalsoftheRheumaticDiseases, 69, 469-471. https://doi.org/10.1136/ard.2009.110411
[6]
Lora, V., Cerroni, L. and Cota, C. (2018) Skin Manifestations of Rheumatoid Arthritis. ItalianJournalofDermatologyandVenereology, 153, 243-255. https://doi.org/10.23736/s0392-0488.18.05872-8
[7]
Scott, D.G.I. and Bacon, P.A. (1984) Intravenous Cyclophosphamide Plus Methylprednisolone in Treatment of Systemic Rheumatoid Vasculitis. TheAmericanJournalofMedicine, 76, 377-384. https://doi.org/10.1016/0002-9343(84)90654-5
[8]
Turesson, C. and Matteson, E.L. (2009) Vasculitis in Rheumatoid Arthritis. CurrentOpinioninRheumatology, 21, 35-40. https://doi.org/10.1097/bor.0b013e32831c5303
[9]
Labarbe, L., Garinat, M., Cornetto, M.A., Gaspard, W., Le Floch, H., Grassin, F., et al. (2022) Un vaisseaux nommé rhumatoïde: À propos d’un cas. LaPresseMédicaleFormation, 3, 279-281. https://doi.org/10.1016/j.lpmfor.2022.03.010
[10]
Bartels, C.M. and Bridges, A.J. (2010) Rheumatoid Vasculitis: Vanishing Menace or Target for New Treatments? CurrentRheumatologyReports, 12, 414-419. https://doi.org/10.1007/s11926-010-0130-1